Pig UCP2 gene segment and application thereof

By providing pig UCP2 gene fragments and stable expression cell lines, the problem of insufficient application of UCP2 gene in the prior art is solved, and the efficient expression of UCP2 gene and oxidative stress resistance in pig cells is achieved, providing research and application tools. , promoted the technological progress of the pig breeding industry.

CN118931912APending Publication Date: 2024-11-12INST OF ANIMAL HUSBANDRY & VETERINARY MEDICINE JIANGXI ACAD OF AGRI SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411268641.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-11
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

In the prior art, there are few researches on the transgenic application of pig UCP2 gene, and there is a lack of effective tools to study the mechanism of UCP2 in pig growth and development and energy metabolism.

Method used

The pig UCP2 gene fragment, its expression vector and stable expression cell line are provided. By constructing recombinant expression vectors and infected pig small intestinal epithelial cells, the UCP2 gene mRNA expression volume is improved, and the UCP2 gene mRNA expression volume is increased. Under oxidative stress conditions, cell viability and antioxidant enzyme activity are significantly improved, ROS levels are reduced, and apoptosis-related gene expression is regulated.

Benefits of technology

It significantly increased the mRNA expression of UCP2 gene, enhanced the resistance of cells to oxidative stress, provided a tool to study UCP2 in pig energy metabolism, antioxidant and fat metabolism, and promoted the technological progress and economic benefits of pig breeding industry. .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118931912A_ABST
    Figure CN118931912A_ABST
Patent Text Reader

Abstract

The invention discloses a pig UCP2 gene segment and application thereof, the nucleotide sequence of the pig UCP2 gene segment is shown as SEQ ID NO.1, and the pig UCP2 gene segment can be used for constructing recombinant expression vectors, recombinant bacteria, transgenic cell lines and the like. The invention constructs a pig UCP2 gene stable expression cell line, which is constructed by lentivirus infected pig small intestine epithelial cells IPEC-1 containing pig UCP2 gene segments, and can stably overexpress the UCP2 gene. The oxidative stress treatment of the cell line shows that the cell activity of the cell line is obviously improved, the intracellular total ROS level is obviously reduced, the activities of intracellular superoxide dismutase, glutathione peroxidase and catalase are all improved, in addition, the cell line also has a regulation effect on apoptosis-related genes, and can be further applied to research on growth and energy conversion efficiency of pigs.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of molecular biology, and in particular to a porcine UCP2 gene fragment and an application thereof. Background Art

[0002] Uncoupling Protein 2 (UCP2) is an important member of the uncoupling protein family and is mainly distributed in the inner membrane of mitochondria. UCP2 regulates proton leakage, reduces the electrochemical gradient of the inner membrane of mitochondria, decouples the oxidative phosphorylation process, reduces ATP synthesis, and releases energy as heat. UCP2 plays a key role in a variety of biological processes, including regulating energy metabolism, heat generation, anti-oxidative stress, cell apoptosis, and immune response.

[0003] As an important economic animal in my country's breeding industry, pigs have a direct impact on economic benefits due to their growth rate, feed utilization and disease resistance. Studies have shown that the UCP2 gene has a rich variety of variations, among which deletion mutations may have a certain effect on the daily weight gain of pig production performance (Li Yanhua, Study on Genetic Variation of Porcine Uncoupling Protein Genes (UCP2 and UCP3), Master's Thesis of China Agricultural University, 2005.05.01). Therefore, the research on porcine uncoupling protein 2 mainly focuses on its gene polymorphism (such as Chinese patents with publication numbers CN1513992A, CN1687411A, and CN107419026A). There are not many studies on the application of UCP2 in transgenics.

[0004] In view of this, the present invention is proposed. Summary of the invention

[0005] The purpose of the present invention is to address the above-mentioned deficiencies in the prior art and provide a new porcine UCP2 gene fragment, as well as an expression vector and a stable expression cell line based on the GIA gene fragment, which provide an important tool for studying the mechanism of action of the UCP2 gene in porcine growth and development and energy metabolism.

[0006] The technical solution of the present invention is described in detail as follows:

[0007] In a first aspect, the present invention provides a porcine UCP2 gene fragment, the nucleotide sequence of which is shown in SEQ ID NO.1, which is a DNA molecule shown in nucleotides 427-1356 of the sequence shown in GeneBank accession number XM_005667098.1. The porcine UCP2 gene fragment can be obtained by amplifying the porcine genome as a template, or by artificial synthesis.

[0008] TGGTTGGATTCAAGGCCACAGAGGTCCCCCCGACTGCCACTGTGAAGTTCCTGGGGGCTGGCACAGCTGCCTGCATCGCAGACCTCATCACCTTTCCCCTGGACACGGCTAAAGTCCGGCTGCAGATCCAGGGAGAAAGGCGGGGGCCAGTGCAGGCCGCGGCCAGTGCCCAGTACCGCGGGGTGCTGGGCACCATTCTCACCATGGTGCGCAACGAGGGCCCCCGCAGCCTCTACAACGGGCTGGTGGCCGGCCTGCAGCGCCAGATGAGCTTCGCCTCCGTCCGCATCGGCCTCTACGACTCCGTCAAGCATTTCTACACCAAGGGCTCAGAGCATGCTGGCATCGGGAGCCGCCTCCTGGCAGGCAGCACCACGGGGGCCTTGGCTGTGGCCGTGGCCCAGCCAACAGACGTGGTAAAGGTCCGGTTCCAAGCGCAGGCCCGGGCCGGCGGAGGCCGGCGGTACCGGAGCACTGTCGACGCCTACAAGACCATCGCCCGAGAGGAGGGGCTGCGGGGCCTCTGGAAAGGGACCTCACCCAATGTCGCTCGTAATGCCATTGTCAACTGTGCTGAGCTGGTGACCTATGACCTCATCAAGGACACGCTCCTGAAGGCCGACCTCATGACAGATGACCTTCCCTGCCACTTCACGTCCGCCTTCGGGGCGGGCTTCTGCACCACCGTCATCGCCTCTCCCGTGGACGTGGTCAAGACGAGATACATGAACTCTGCCCCGGGCCAGTACAGCAGCGCTGGCCACTGTGCCCTCACCATGCTCCAGAAGGAGGGTCCCCGAGCCTTCTACAAAGGGTTCACGCCCTCCTTTCTCCGATTGGGGTCCTGGAACGTGGTGATGTTTGTCACCTATGAGCAGCTGAAGAGGGCCCTCATGGCTGCCCGCGCTTCCCGGGAGGCTCCCTTTTGA(SEQ ID NO.1)。

[0009] In a second aspect, the present invention provides a primer pair for amplifying the above-mentioned pig UCP2 gene fragment, the nucleotide sequence of which is shown in SEQ ID NO.2-3.

[0010] In a third aspect, the present invention provides a recombinant expression vector comprising the above-mentioned porcine UCP2 gene fragment, or comprising an expression cassette carrying the above-mentioned porcine UCP2 gene fragment.

[0011] Optionally or preferably, the above-mentioned recombinant expression vector is constructed by inserting the above-mentioned porcine UCP2 gene fragment between the EcoR I and BamH I multiple cloning sites of the lentiviral expression vector pHBLV-CMVIE-ZsGreen-Puro.

[0012] In a fourth aspect, the present invention provides a recombinant bacterium comprising the above-mentioned porcine UCP2 gene fragment or the above-mentioned recombinant expression vector.

[0013] In a fifth aspect, the present invention provides a cell line stably expressing the porcine UCP2 gene, which is constructed by infecting porcine small intestinal epithelial cells IPEC-1 with a lentivirus containing the porcine UCP2 gene fragment.

[0014] In a sixth aspect, the present invention provides a method for preparing the above-mentioned porcine UCP2 gene stably expressing cell line, comprising the following steps:

[0015] (1) RNA was extracted from pig tissues and reverse transcribed to obtain cDNA, and specific primers were designed to perform PCR amplification to obtain the pig UCP2 gene fragment;

[0016] (2) Connecting the purified porcine UCP2 gene fragment to the linearized lentiviral expression vector pHBLV-CMVIE-ZsGreen-Puro, and transforming competent cells to obtain the recombinant expression vector pHBLV-CMVIE-ZsGreen-Puro-UCP2;

[0017] (3) Transfecting 293T cells with the three-plasmid packaging system containing pHBLV-CMVIE-ZsGreen-Puro-UCP2 and culturing to obtain a virus suspension;

[0018] (4) Virus particles were harvested from the virus suspension and used to infect porcine small intestinal epithelial cells IPEC-1 for gene integration to obtain a cell line stably expressing the porcine UCP2 gene.

[0019] Compared with the prior art, the present invention has the following beneficial effects:

[0020] Compared with normal porcine intestinal epithelial cells, the intracellular UCP2 gene mRNA expression level of the porcine UCP2 gene stably expressing cell line IPEC-1-UCP2 of the present invention increased by 42.46 times. Compared with the intestinal epithelial cells expressing UCP2 normally, after the hydrogen peroxide oxidative stress intervention, the cell viability of IPEC-1-UCP2 was significantly improved (P<0.05), and the total intracellular ROS level was significantly reduced; the intracellular superoxide dismutase, glutathione peroxidase, and catalase activities of IPEC-1-UCP2 were significantly higher than those of the intestinal epithelial cells expressing UCP2 normally. Compared with the normal porcine intestinal epithelial cell group, hydrogen peroxide oxidative stress intervention can significantly increase the expression of IPEC-1-UCP2 apoptosis inhibitor gene Bcl-2 (P<0.05), and reduce the expression of pro-apoptosis related genes Fas, Caspase-3 and Bax, among which the effect on Bax expression reached a significant level (P<0.05).

[0021] The porcine UCP2 gene stably expressing cell line constructed by the present invention not only provides an effective tool for studying the specific biological functions of UCP2 in pigs, helps to deeply understand the role of UCP2 in energy metabolism, anti-oxidation and fat metabolism, but also can provide technical support in the fields of optimizing pig nutrition programs, improving feed utilization and production performance, so as to further develop new feed additives and therapeutic drugs for improving pig production performance, and promote technological progress and economic benefits of the pig farming industry. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 This is the agarose gel electrophoresis diagram of the PCR amplification product of the porcine UCP2 gene and the linearized pHBLV-CMVIE-ZsGreen-Puro vector.

[0023] Figure 2 The fluorescence microscope and bright field photos of IPEC-1-UCP2 cells; the bar graph is the fluorescence quantitative PCR detection results of UCP2 gene mRNA in IPEC-1-UCP2 cells.

[0024] Figure 3 H 2 O 2 Results of the effects of induced oxidative stress on the viability of IPEC-1-UCP2 cells.

[0025] Figure 4 H 2 O 2 Results of the effects of induced oxidative stress on the activities of antioxidant enzymes in IPEC-1-UCP2 cells.

[0026] Figure 5 H 2 O 2Results of the effects of induced oxidative stress on the expression of apoptosis-related genes in IPEC-1-UCP2 cells. DETAILED DESCRIPTION

[0027] In order to make those skilled in the art better understand the present application scheme, the present application will be clearly and completely described below in conjunction with the embodiments and drawings. Obviously, the described embodiments are only embodiments of a part of the present application, rather than all embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in the field without making creative work should belong to the scope of protection of this application. The instruments and reagents used in the embodiments are all derived from commercial channels unless otherwise specified. The methods used in the embodiments are all conventional methods unless otherwise specified.

[0028] Example 1 Construction of UCP2 gene overexpression lentiviral vector

[0029] (1) Obtaining pig UCP2 gene fragment

[0030] RNA was extracted from pig jejunum tissue and reverse transcribed to obtain cDNA. PCR amplification was performed using the cDNA as a template using the upstream primer F and downstream primer R listed below.

[0031] Upstream primer F: ATA GAATTC GCCACCATGGTTGGATTCAAGGCCA (SEQ ID NO. 2);

[0032] Downstream primer R: ATA GGATCC AAAGGGAGCCTCCCGGGA (SEQ ID NO. 3).

[0033] The underlined parts are: F, EcoR I restriction site; R, BamH I restriction site.

[0034] The PCR reaction system is shown in Table 1:

[0035] Table 1. PCR reaction system

[0036]

[0037] The PCR reaction conditions were as follows: 95°C pre-denaturation for 5 min, 94°C denaturation for 20 s, 55°C annealing for 20 s, 72°C extension for 90 s, 25 cycles in total, and 72°C extension for 10 min. The target gene fragment was verified by agarose gel electrophoresis and recovered by DNA purification kit. Figure 1 The rightmost picture shows the electrophoresis of the PCR amplification product of the porcine UCP2 gene fragment, showing strong fluorescence at 750-1000bp, indicating that the amplified product is correct.

[0038] (2) Construction of UCP2 lentiviral expression vector

[0039] The commercial pHBLV-CMVIE-ZsGreen-Puro vector was linearized using restriction enzymes EcoR I and BamH I ( Figure 1 The linearized vector was recovered and connected with the PCR product of step (1). The connected product was transformed into competent Escherichia coli DH5α cells, and the positive clones were sequenced and identified. The results showed that the porcine UCP2 gene fragment DNA molecule shown in SEQ ID NO.1 was inserted into the multiple cloning sites EcoR I and BamH I of the pHBLV-CMVIE-ZsGreen-Puro vector, and the UCP2 lentiviral expression vector was successfully constructed and named pHBLV-CMVIE-ZsGreen-Puro-UCP2.

[0040] Example 2 UCP2 Lentiviral Particle Packaging

[0041] Virus particles were assembled using a three-plasmid system (pHBLV-CMVIE-ZsGreen-Puro-UCP2, pSPAX2, pMD2G). TM The three plasmids were co-transfected into 293T cells with transfection reagents, and the culture medium was replaced with complete medium 6 hours after transfection. After culturing for 48 hours and 72 hours, the cell supernatant was collected and concentrated by ultracentrifugation to obtain a high-titer lentiviral concentrate.

[0042] The lentiviral titer (transduction unit, TU) was determined by digesting and counting 293T cells in good growth state and then diluting them to 1×10 5 / mL, 100 μL / well of 96-well plate, incubate at 37°C, 5% CO 2 Overnight culture under the conditions. 293T cells in 96-well plates were infected with gradient dilutions of lentivirus, and 24 hours later, the medium was replaced with 2.5 μg / mL puromycin. Virus titer was observed and calculated after 96 hours. The results showed that the UCP2 lentivirus titer was 1×10 8 TU / mL.

[0043] Example 3. Construction of UCP2-overexpressing porcine intestinal epithelial cell line

[0044] Porcine intestinal epithelial cells IPEC-1 were cultured at 5×10 5The number of cells was inoculated into a 6-well plate, and UCP2 lentivirus was added to each well at an MOI of 10. After 48 hours of culture, the medium containing 1 μg / mL puromycin was replaced for screening. After the cell growth stabilized, the cells could be passaged. After two generations of cell passage culture, the cells were frozen. The cell morphology of the reconstructed line was observed under a fluorescence microscope. The results showed that the cell outline was clear and the cell morphology was typical, such as Figure 2 -B; Due to the integration of the tag protein carried by pHBLV-CMVIE-ZsGreen-Puro-UCP2, a large amount of green fluorescent protein can be seen, such as Figure 2 As shown in Figure 5A, the above cells were named IPEC-1-UCP2.

[0045] Identification of overexpression of UCP2 mRNA in IPEC-1-UCP2. Specifically, IPEC-1-UCP2 cells and normal IPEC-1 cells were inoculated in 6-well plates and cultured to the logarithmic growth phase. Total cell RNA was extracted and reverse transcribed into cDNA. Using sGAPDH as the housekeeping gene, fluorescence quantitative PCR was used to determine the expression level of UCP2 gene mRNA. The results showed that compared with normal intestinal epithelial cells, the expression of UCP2 gene mRNA in IPEC-1-UCP2 cells increased by 42.46 times. Figure 2 -C.

[0046] Example 4. IPEC-1-UCP2 cell line can regulate cell function under oxidative stress

[0047] (1)H 2 O 2 Effects of induced oxidative stress on the viability of IPEC-1-UCP2 cells

[0048] a. Take IPEC-1-UCP2 cells and normal intestinal epithelial cells in logarithmic growth phase and use 1×10 5 / well of a 96-well plate and cultured for 24 h to allow adhesion.

[0049] b. In the stress group, 10 μL 1 mM hydrogen peroxide was added to the culture medium; in the control group, PBS was added and the hydrogen peroxide was immediately removed after 1 h.

[0050] After washing with sterile PBS, 100 μL of phenol red-free 1640 medium and 10 μL of CCK-8 reagent were added, incubated at 37°C for 2 h, and the absorbance at 490 nm was measured with an enzyme marker to calculate the cell viability. The results showed that compared with intestinal epithelial cells that normally expressed UCP2, the viability of IPEC-1-UCP2 cells was significantly improved after hydrogen peroxide treatment (P<0.05), see Figure 3 .

[0051] (2)H 2 O2 Effects of induced oxidative stress on the activities of antioxidant enzymes in IPEC-1-UCP2 cells

[0052] The treatment of the stress group and the control group was the same as a and b. The activities of superoxide dismutase, glutathione peroxidase and catalase were determined by hydroxylamine method, colorimetric method and ammonium molybdate method respectively. The specific operation steps are shown in the instructions for use of the kit. The results showed that after hydrogen peroxide treatment, the activities of superoxide dismutase, glutathione peroxidase and catalase in IPEC-1-UCP2 cells were significantly higher than those in normal intestinal epithelial cells expressing UCP2 (P<0.05), see Figure 4 .

[0053] (3)H 2 O 2 Effects of induced oxidative stress on the expression of apoptosis-related genes in IPEC-1-UCP2 cells

[0054] The treatment of the stress group and the control group was the same as a and b. Fluorescence quantitative PCR was used to detect the expression levels of apoptosis-related genes. The results showed that compared with the normal intestinal epithelial cell group, oxidative stress could significantly increase the expression of apoptosis-inhibiting gene Bcl-2 in IPEC-1-UCP2 cells (P<0.05), and reduce the expression of pro-apoptosis-related genes Fas, Caspase-3 and Bax, among which the effect on Bax expression reached a significant level (P<0.05), see Figure 5 .

[0055] The experimental results show that the cell line IPEC-1-UCP2 constructed by the present invention can stably overexpress the UCP2 gene, and the mRNA expression level is increased by 42.46 times compared with normal cells. In addition, after oxidative stress, cell viability can be significantly improved, and the total intracellular ROS level is significantly reduced; the activities of superoxide dismutase, glutathione peroxidase, and catalase are significantly higher than those of normal cells. After oxidative stress treatment, the expression of intracellular apoptosis-inhibiting genes is increased, and the expression of pro-apoptosis-related genes is decreased, indicating that it can effectively resist the damage of oxidative stress to cells.

[0056] The IPEC-1-UCP2 cell line of the present invention can be further used to study the nutritional program of pigs and improve feed utilization and production performance.

[0057] The invention concept is described in detail using specific examples herein, and the description of the above embodiments is only used to help understand the core idea of ​​the invention. It should be pointed out that any obvious modification, equivalent substitution or other improvement made by a person of ordinary skill in the art without departing from the invention concept should be included in the protection scope of the present invention.

Claims

1. Porcine UCP2 gene fragment, It is characterized in that The nucleotide sequence is shown in SEQ ID NO.

1.

2. A primer pair for amplifying the porcine UCP2 gene fragment according to claim 1, It is characterized in that The nucleotide sequence is shown in SEQ ID NO.2-3.

3. A recombinant expression vector, It is characterized in that It comprises the porcine UCP2 gene fragment as claimed in claim 1, or comprises an expression cassette carrying the porcine UCP2 gene fragment as claimed in claim 1.

4. The recombinant expression vector according to claim 3, It is characterized in that The porcine UCP2 gene fragment according to claim 1 is inserted between the EcoR I and BamH I multiple cloning sites of the lentiviral expression vector pHBLV-CMVIE-ZsGreen-Puro.

5. A recombinant bacterium, It is characterized in that It comprises the porcine UCP2 gene fragment according to claim 1, or the recombinant expression vector according to claim 3, or the recombinant expression vector according to claim 4.

6. A cell line stably expressing the porcine UCP2 gene, It is characterized in that The method is constructed by infecting pig small intestinal epithelial cells IPEC-1 with a lentivirus containing the pig UCP2 gene fragment of claim 1.

7. The method for preparing the cell line stably expressing the porcine UCP2 gene according to claim 6, It is characterized in that The following steps are involved: (1) RNA was extracted from pig tissues and reverse transcribed to obtain cDNA, and specific primers were designed to perform PCR amplification to obtain the pig UCP2 gene fragment; (2) Connecting the purified porcine UCP2 gene fragment to the linearized lentiviral expression vector pHBLV-CMVIE-ZsGreen-Puro, and transforming competent cells to obtain the recombinant expression vector pHBLV-CMVIE-ZsGreen-Puro-UCP2; (3) Transfecting 293T cells with the three-plasmid packaging system containing pHBLV-CMVIE-ZsGreen-Puro-UCP2 and culturing to obtain a virus suspension; (4) Virus particles were harvested from the virus suspension and used to infect porcine small intestinal epithelial cells IPEC-1 for gene integration to obtain a cell line stably expressing the porcine UCP2 gene.